EGFR and cancer: G protein coupled receptors (GPCRs), Integrins, sigma receptors, Epidermal growth factor receptor, Sigma receptors (SRs) these over expressed receptors are frequently used in preclinical cancer models for selective drug delivery via receptor–ligand pairs (Rana and Bhatnagar, 2021).